| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |